Tuesday, September 16, 2014 Last update: 2:33 PM
FreshNews.com - All Company Technology News Since 1996

U.S. Large-Joint Reconstructive Implant Market Will Reach $8.8 Billion by 2022

Companies mentioned in this article: Decision Resources Group

BURLINGTON, Mass., June 5, 2014 /PRNewswire/ -- Decision Resources Group finds that the United States large-joint reconstructive implant market will grow to a value of $8.8 billion in 2022, primarily as a result of the aging population because the elderly are most at risk of developing severe osteoarthritis. Market growth will, however, be dampened by the increasing activity of group purchasing organizations, which allow hospitals to buy products such as reconstructive implants in bulk at a discount. As a result, market expansion will be modest through 2022.


Other key findings from Decisions Resources Group's coverage of the U.S. large-joint reconstructive implant market:

    --  Implementation of ACA: The market, particularly the knee implant
        segment, experienced an unexpected uptick at the end of 2013 as patients
        and practitioners who were concerned about effects of the implementation
        of the Affordable Care Act (ACA) decided to pull procedures that would
        have been scheduled at the beginning of 2014 into 2013.
    --  Shift from MOM to COC hip implants: The decline in the popularity of hip
        resurfacing as well as metal-on-metal (MOM) hip implants will continue,
        with the strongest decline occurring over the next few years. This shift
        will facilitate re-adoption of ceramic-on-ceramic (COC) implants as
        physicians show increasing confidence in new COC designs, which have
        resolved prior concerns related to audible postoperative implant
    --  Stagnating innovation: Although the launch of premium products can
        normally help to offset price declines, surgeons continue to show a
        preference for older-generation implants that have a proven track
        record. Combined with the recently implemented medical device excise tax
        and increasing difficulty in obtaining Food and Drug Administration
        approval, many companies will reduce their operating costs (including
        R&D budgets) and innovation will suffer as a result.

Comments from Decision Resources Group Senior Analyst Brady Baker:

    --  "The market has undergone significant consolidation over the past year.
        First, in 2013, Stryker acquired MAKO Surgical, representing the first
        investment in robotic surgery technology from a major competitor in the
        large-joint reconstructive implant market. Robotic assistance was used
        in approximately 15,000 knee reconstructive implant of procedures in
    --  "The most significant news in this market has been Zimmer's recent
        announcement of intent to acquire rival Biomet. This acquisition is
        expected to close in 2015 and will solidify Zimmer as the market leader
        in the large-joint reconstructive implant market, with approximately
        one-third of total market share."

Additional Resources:

    --  Brady Baker has written a Medtech 360 report on this subject entitled US
        Markets for Large-Joint Reconstructive Devices 2014.
    --  Decision Resources Group's Marketrack, which provides market share data
        by brand for the large-joint reconstructive implant device market, can
        be found here.

About Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. Clients rely on this analysis and data to make informed decisions. Find out more at www.DecisionResourcesGroup.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Decision Resources Group
Christopher Comfort

Logo - http://photos.prnewswire.com/prnh/20130103/MM36768LOGO

SOURCE Decision Resources Group